{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 959"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Federal Food, Drug, and Cosmetic Act with\n\t\t  respect to compounding drugs."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130515", "#text": "May 15, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor,\n\t\t\t and Pensions"}, "sponsor": {"#tail": " (for himself,\n\t\t\t ", "#text": "Mr. Harkin", "@name-id": "S172"}, "cosponsor": [{"#tail": ", ", "#text": "Mr. Alexander", "@name-id": "S289"}, {"#tail": ", ", "#text": "Mr. Roberts", "@name-id": "S260"}, {"#tail": ", and ", "#text": "Mr.\n\t\t\t Franken", "@name-id": "S332"}, {"#tail": ")\n\t\t\t introduced the following bill; which was read twice and referred to the\n\t\t\t ", "#text": "Ms. Mikulski", "@name-id": "S182"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@dms-id": "A1", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n\t\t\t", "#text": "Short\n\t\t\t title; references in Act"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": {"short-title": {"#tail": "\n          ", "#text": "Pharmaceutical Compounding\n\t\t\t Quality and Accountability Act"}, "#tail": ".", "#text": "\n            "}, "#text": "This Act may be cited\n\t\t\t as the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Short\n\t\t\t title"}, "#text": "\n        ", "@id": "id8ACC258572204D83A85EA1849E53718F"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "Except as otherwise specified, amendments made by this Act to\n\t\t\t a section or other provision of law are amendments to such section or other\n\t\t\t provision of the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 301 et\n\t\t\t seq.", "@value": "usc/21/301/etseq"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "References in\n\t\t\t Act"}, "#text": "\n        ", "@id": "id21541D659B854E34B45AF7A32A158413"}], "#text": "\n      ", "@id": "S1"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Regulation of\n\t\t\t human and animal drug compounding"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": [{"#tail": " (as defined in ", "#text": "new drug"}, {"#tail": " (as defined in ", "#text": "new animal drug"}], "#text": "For purposes of the\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", the terms\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 301 et seq.", "@value": "usc/21/301/etseq"}, "@parsable-cite": "usc/21/301", "#text": "\n              ", "@legal-doc": "usc"}}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ") and\n\t\t\t ", "@entity-type": "act", "#text": "section 201(p) of such Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:201/ss:p"}, {"#tail": ") shall\n\t\t\t include a compounded human drug and a compounded animal drug,\n\t\t\t respectively.", "@entity-type": "act", "#text": "section 201(v) of such Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:201/ss:v"}]}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Clarification\n\t\t\t of new drug and new animal drug status"}, "#text": "\n        ", "@id": "id3721FE4A11DE4BC59EDB730C55A347BC"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 353a", "@value": "usc/21/353a"}, "@parsable-cite": "usc/21/353a", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Regulation of\n\t\t\t human and animal drug compounding"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "503A."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Human and\n\t\t\t\tanimal drug compounding"}, "subsection": [{"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Scope"}, "paragraph": [{"#tail": "\n              ", "@id": "id69BD248E560D4070A2A7680A26813ADE", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Compounding"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": [{"#tail": " and\n\t\t\t\t", "#text": "compounding"}, {"#tail": "\u2014", "#text": "compound"}], "#text": "In\n\t\t\t\tthis section, the terms "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "include\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the combining,\n\t\t\t\tadmixing, mixing, diluting, reconstituting, or otherwise altering of a marketed\n\t\t\t\tdrug;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id743AE1FA4C0E42198D7740AC4F2EA2C9", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "compounding a\n\t\t\t\tdrug from a bulk drug substance; and"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id2CD6F08226F44A0D82CC25E137729990", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "subsection (b)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:5", "@proposed": "true"}, "#text": "repackaging, as\n\t\t\t\tdefined in "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "idA522786264244150859106801D9745FD", "#text": "\n                    "}], "#text": "\n                  ", "@id": "idCF793E06B2BE4B3FB31A2D7C6526E526"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "exclude mixing,\n\t\t\t\treconstituting, or other such acts with respect to a marketed drug that are\n\t\t\t\tlimited to and performed solely in accordance with specific directions for such\n\t\t\t\tacts contained in approved labeling provided by a drug\u2019s manufacturer, when\n\t\t\t\tperformed upon receipt of a prescription order for an identified individual\n\t\t\t\tpatient."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id79E6A4A9124843DEA4E25E62C77D6431", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": [{"#tail": " or\n\t\t\t\t", "#text": "sell"}, {"#tail": " do not include dispensing to patients, or, in the case of\n\t\t\t\tanimal drugs, to the individual responsible for providing care for the animal\n\t\t\t\tfor which the drug is intended, in accordance with State law, including any fee\n\t\t\t\tassociated with such dispensing.", "#text": "resale"}], "#text": "In this section, the terms "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Dispensing not\n\t\t\t\ta sale"}, "#text": "\n                ", "@id": "idDB8DF24CECA14CB1B6558BD84C478822"}, {"#tail": "\n            ", "@id": "idF0ACB41105174CA2B39439C192726FCE", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Exemptions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "This\n\t\t\t\tsection shall not apply to\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "medical\n\t\t\t\tgases;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id677477944B45431999200DB6EE0EFD30", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under the Act commonly known as the ", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t\tAgriculture", "@entity-id": "1200"}, {"#tail": ";\n\t\t\t\tor", "@entity-type": "act", "#text": "Virus-Serum-Toxin Act", "@value": "Virus-Serum-Toxin Act"}], "#text": "animal drugs that\n\t\t\t\tare subject to regulation as biological products by the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id4BDBC6F85E404AC08AE5DEB6ED190072", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "human blood and\n\t\t\t\tblood components for transfusion."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id3D59E4A42AEB4A058EFF0FA7D542035F", "#text": "\n                  "}]}], "#text": "\n              ", "@id": "id124AC6E0C1C04219970442F4C28E98BA"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis section:"}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "that compounds\n\t\t\t\tany sterile drug product without receiving a prescription order for such\n\t\t\t\tsterile drug product prior to beginning compounding, and distributes or offers\n\t\t\t\tto sell such compounded sterile drug product in interstate commerce; or"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "id6C27B5F97EEE46FD8EEC39A3F21C52DD", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (7)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:7/sp:B", "@proposed": "true"}, "#text": "that repackages\n\t\t\t\tany preservative-free sterile drug product or pools any sterile drug products,\n\t\t\t\texcept as provided in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "idAB3BAAAA0F7448589213D2825F1A1354", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means a\n\t\t\t\tfacility at one geographic location or address\u2014", "#text": "compounding manufacturer"}, "#text": "The term "}, "#text": "\n                  ", "@id": "idDDE1701134694C26B76AA2D207CCF86E", "@commented": "no"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or the final guidance described in ", "@entity-type": "act", "#text": "section 506F", "@value": "Federal Food, Drug, and Cosmetic Act/s:506F"}, {"#tail": "; and", "@entity-type": "act", "#text": "section\n\t\t\t\t506F(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:506F/ss:d"}], "#text": "repackages drugs\n\t\t\t\tin accordance with "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "id6D8DB87DFE854CB68F6870419C69C15A", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1/sp:A", "@proposed": "true"}, "#text": "does not\n\t\t\t\totherwise meet the definition of compounding manufacturer under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "idD9F9FE13577B4CA89808ED5695E9C45A", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Excluded\n\t\t\t\tactivities"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a facility shall\n\t\t\t\tnot be considered a compounding manufacturer if such facility\u2014", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1/sp:A/cl:ii", "@proposed": "true"}, "#text": "Notwithstanding "}, "#text": "\n                  ", "@id": "idAF7B050D7E88489E91892A734C70EB43", "@commented": "no"}], "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Compounding\n\t\t\t\tmanufacturer"}, "#text": "\n                ", "@id": "id997D23D17191491D89FBFDEC74806287", "@commented": "no"}, {"#tail": "\n              ", "@id": "id623299A87E57435B8DEA7B4F245D4D6E", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Pooling;\n\t\t\t\tpools"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": [{"#tail": " and\n\t\t\t\t", "#text": "pooling"}, {"#tail": "\u2014", "#text": "pool"}], "#text": "The terms "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ", conditionally approved under\n\t\t\t\t", "@entity-type": "act", "#text": "512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": ", included on the index established under ", "@entity-type": "act", "#text": "section 571", "@value": "Federal Food, Drug, and Cosmetic Act/s:571"}, {"#tail": ", or\n\t\t\t\tlicensed under ", "@entity-type": "act", "#text": "section 572(a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:572/ss:a/p:1"}, {"#tail": " from the container\n\t\t\t\tin which it is distributed by the original manufacturer and combining it with\n\t\t\t\tthe same drug from one or more other containers without or before further\n\t\t\t\tmanipulating the product (such as by diluting it or mixing it with another,\n\t\t\t\tdifferent drug or drugs);", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "#text": "mean taking a\n\t\t\t\tsingle drug approved under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "#text": "\n                  ", "@id": "id6B2CBCE2FA774D859D9D198AA977298E", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "do not include\n\t\t\t\tcombining the drug from two or more separate containers of the same drug when a\n\t\t\t\tsingle container of the drug is not sufficient to prepare a single dose for\n\t\t\t\tadministration to an individual patient; and"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "idFC156E6EDE9C43D282048AAFAB965A0B", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "do not include\n\t\t\t\tcombining the drug from two or more separate containers of component products\n\t\t\t\tof a total parenteral nutrition product, if such pooling, and labeling and use\n\t\t\t\tof the finished total parenteral nutrition product, comply with State pharmacy\n\t\t\t\tlaw."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "#text": "\n                  ", "@id": "idAA22CDC4EC61454F939C294463A5D191", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " includes a physician, veterinarian, or any other\n\t\t\t\tperson that is authorized to prescribe medication under State law.", "#text": "practitioner"}, "#text": "The\n\t\t\t\tterm "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Practitioner"}, "#text": "\n                ", "@id": "id9A507F19BC7144BBBFD05655FCB5E324", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": [{"#tail": " or\n\t\t\t\t", "#text": "prescription"}, {"#tail": " means a prescription or prescription order, as\n\t\t\t\tdefined under applicable State law, that complies with requirements applicable\n\t\t\t\tunder such State law.", "#text": "prescription order"}], "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Prescription;\n\t\t\t\tprescription order"}, "#text": "\n                ", "@id": "id1E27EC8457A64DB2B5D1FD1BE3D0BD0A", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ",\n\t\t\t\tconditionally approved under ", "@entity-type": "act", "#text": "512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": ", included on the index established\n\t\t\t\tunder ", "@entity-type": "act", "#text": "section 571", "@value": "Federal Food, Drug, and Cosmetic Act/s:571"}, {"#tail": ", or licensed under ", "@entity-type": "act", "#text": "section 572(a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:572/ss:a/p:1"}, {"#tail": " from the container in which it is distributed by the original\n\t\t\t\tmanufacturer and placing it in a different container of the same or smaller\n\t\t\t\tsize without further manipulating the drug (such as by diluting it or mixing it\n\t\t\t\twith another, different drug or drugs), unless such repackaging is done\n\t\t\t\tpursuant to a prescription for an identified individual patient.", "@entity-type": "act", "#text": "section 351 of the Public Health\n\t\t\t\tService Act", "@value": "Public Health Service Act/s:351"}], "term": [{"#tail": " or\n\t\t\t\t", "#text": "repackage"}, {"#tail": " means taking a drug approved under ", "#text": "repackaging"}], "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Repackage or\n\t\t\t\trepackaging"}, "#text": "\n                ", "@id": "id21CDB1BA3A8E4F0B8E1CE97AF20459DF", "@commented": "no"}, {"#tail": "\n              ", "@id": "idCE32000E5D2A4E67A229ACB28ADCE88D", "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n                ", "#text": "Sterile drug\n\t\t\t\tproduct"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means a drug\n\t\t\t\tthat is\u2014", "#text": "sterile drug product"}, "#text": "The term "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "intended for\n\t\t\t\tparenteral administration;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "#text": "\n                  ", "@id": "id2A1A2FFA331B46CBABF4D482B1C297DF", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "an ophthalmic or\n\t\t\t\tinhalation drug; or"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "idE3172D2848704D31ACA8D2A1E19EA6DF", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "required to be\n\t\t\t\tsterile under Federal or State law."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "#text": "\n                  ", "@id": "id7419382B9DB64E7CB7B47E497D128C67", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "wherein a drug is\n\t\t\t\tcompounded by\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "a licensed\n\t\t\t\tpharmacist, or other pharmacy personnel (to the extent permitted under State\n\t\t\t\tlaw), in a State-licensed pharmacy or a Federal facility; or"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "idf578b68c17e44a4cb168aae084dbff2b", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "a licensed\n\t\t\t\tphysician or licensed veterinarian, to the extent permitted under State\n\t\t\t\tlaw;"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "idc7f9d6b19ed341aeaf87cedf5ac3c9fb", "#text": "\n                      "}], "#text": "\n                    ", "@id": "idfbb004eb9ee14dc29877477b50f3ee6b"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "that\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "compounds a drug\n\t\t\t\tupon receipt of a prescription order for an identified individual patient;\n\t\t\t\tor"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "idF74B050AC47A4F679665A2245371C6AB", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "compounds a drug\n\t\t\t\tin limited quantities before receipt of a prescription order for an identified\n\t\t\t\tindividual patient, to the extent permitted under State law, if such\n\t\t\t\tcompounding is based on a history of the licensed pharmacist, licensed\n\t\t\t\tphysician, or licensed veterinarian receiving prescription orders for the\n\t\t\t\tcompounding of the drug, which orders have been generated solely within an\n\t\t\t\testablished relationship between the licensed pharmacist, licensed physician,\n\t\t\t\tor licensed veterinarian and\u2014"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "item": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "such individual\n\t\t\t\tpatient for whom the prescription order will be provided, or, in the case of an\n\t\t\t\tanimal drug, such individual responsible for providing care for the animal for\n\t\t\t\twhich the drug is ordered; or"}, "enum": {"#tail": "\n                        ", "#text": "(aa)"}, "#text": "\n                        ", "@id": "id7B6A562DF5E145A984E0C67A4EABC6D4", "@commented": "no"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the licensed\n\t\t\t\tphysician, licensed veterinarian, or other licensed practitioner who will write\n\t\t\t\tsuch prescription order; and"}, "enum": {"#tail": "\n                        ", "#text": "(bb)"}, "@id": "idDF65B5F40E7F4160A479610C15A860F0", "#text": "\n                        "}], "#text": "\n                      ", "@id": "id0922AEE1A8CF4215BE241F78F6DE9B31", "@commented": "no"}], "#text": "\n                    ", "@id": "id72e1ac26cc6244108fb41bf5d84491e7"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1", "@proposed": "true"}, "#text": "that does not\n\t\t\t\tmeet the definition of a compounding manufacturer under "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "#text": "\n                    ", "@id": "idd1bc3823bd5349409d0b0cfe12b07c31", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means an\n\t\t\t\tentity\u2014", "#text": "traditional compounder"}, "#text": "The term "}, "#text": "\n                  ", "@id": "id3B9501FEA4BB4724AAA3964C932A65E2", "@commented": "no"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:7/sp:A", "@proposed": "true"}, "#text": "A pharmacy within a hospital, veterinary hospital, or\n\t\t\t\thealth system that compounds a drug and dispenses such drug (which may include\n\t\t\t\tinterstate shipment) within such hospital or health system or ships such drug\n\t\t\t\tfor dispensing to patients with an established relationship with the hospital\n\t\t\t\tor health system (which may include interstate shipment), or that repackages\n\t\t\t\tpreservative-free sterile drug product or pools sterile drug products, shall be\n\t\t\t\tconsidered a traditional compounder if such pharmacy otherwise meets the\n\t\t\t\tdefinition under "}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                      ", "@id": "id9A9E7AC43A8C42CDA7BB07607861BD83", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means two or more hospitals or veterinary hospitals that are\n\t\t\t\towned and operated by the same entity and that share access to databases with\n\t\t\t\tdrug order information for patients or animals, as applicable. A health system\n\t\t\t\tincludes both the inpatient and outpatient facilities of hospitals within the\n\t\t\t\thealth system.", "#text": "health\n\t\t\t\tsystem"}, "#text": "For purposes of this subparagraph, the term "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "header": {"#tail": "\n                      ", "#text": "Health system\n\t\t\t\tdefined"}, "#text": "\n                      ", "@id": "idC873139368D648A191D90864BA539C83", "@commented": "no"}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Hospitals and\n\t\t\t\thealth systems"}, "#text": "\n                    ", "@id": "id89348358A8F7472CB12861EC80C931CE", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1/sp:A", "@proposed": "true"}, "#text": "A pharmacy that compounds positron emission\n\t\t\t\ttomography drugs or radiopharmaceuticals shall be considered a traditional\n\t\t\t\tcompounder if it does not compound other drugs that would cause it to be a\n\t\t\t\tcompounding manufacturer described in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "PET and\n\t\t\t\tradiopharmaceuticals"}, "#text": "\n                    ", "@id": "id4254BC5B2EB944BC9E494758DE8B7E11", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Exceptions"}, "#text": "\n                  ", "@id": "id4fb5a2b0e8d64003991312ef5c0dba59", "@commented": "no"}], "enum": {"#tail": "\n                ", "#text": "(7)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Traditional\n\t\t\t\tcompounder"}, "#text": "\n                ", "@id": "id410980F3625745EC9972151B917D822F", "@commented": "no"}], "#text": "\n              ", "@id": "idDD20BCCAB9664E798DBF7C6632E7F85B"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Exemptions from\n\t\t\t\tcertain requirements"}, "paragraph": [{"#tail": "\n              ", "@id": "idD5C461E3CF364B4FA82EEEA954D5CE0E", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Drugs\n\t\t\t\tcompounded by traditional compounders"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t\t", "@entity-type": "act", "#text": "Sections 501(a)(2)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:501/ss:a/p:2/sp:B"}, {"#tail": ", ", "@entity-type": "act", "#text": "502(f)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:f/p:1"}, {"#tail": " (in the case of a human drug), ", "@entity-type": "act", "#text": "505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " (in the case of an\n\t\t\t\tanimal drug), and ", "@entity-type": "act", "#text": "section 512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": " (in the case of\n\t\t\t\ta biological product) shall not apply to a compounded drug if such drug\u2014", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "#text": "\n                  "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is compounded by\n\t\t\t\ta traditional compounder that is in compliance with this section; and"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idAFE6CF4A1E854AB08A028FDBDEC7CBF9", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "meets the\n\t\t\t\trequirements of this section applicable to drugs compounded by traditional\n\t\t\t\tcompounders."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id93126E8B6795458996584A7EC608C561", "#text": "\n                  "}]}, {"#tail": "\n            ", "@id": "id2C92B90EEF024CE694E5F0E8AB8B934B", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Drugs\n\t\t\t\tcompounded by compounding manufacturers"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "Sections 502(f)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:f/p:1"}, {"#tail": "\n\t\t\t\t(in the case of a human drug), ", "@entity-type": "act", "#text": "505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " (in the case of an animal drug), and\n\t\t\t\t", "@entity-type": "act", "#text": "section 512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": " (in the case of a biological\n\t\t\t\tproduct) shall not apply to a compounded prescription drug if such drug\u2014", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "#text": "\n                  "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "is compounded by\n\t\t\t\ta compounding manufacturer\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "that is not\n\t\t\t\tlicensed as a pharmacy in any State; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id4287B01B938B4B3094779C200B1BCD45", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "that is in\n\t\t\t\tcompliance with this section; and"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idFF97E921A2494C9D9D7ECAB12246A1C9", "#text": "\n                    "}], "#text": "\n                  ", "@id": "id9A4FD255941449C88F9C2D7F2CF75685"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "meets the\n\t\t\t\trequirements of this section applicable to drugs compounded by compounding\n\t\t\t\tmanufacturers."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id876394A169354A2BB99BCC233B6CB079", "#text": "\n                  "}]}], "#text": "\n              ", "@id": "id68E8D19962D245109458F8997CCEADAB"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Drugs that may\n\t\t\t\tnot be compounded"}, "paragraph": [{"#tail": "\n              ", "@id": "id9BAE43418C2041569D9B65180E2D8ED1", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ":", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The following drugs may not be compounded, except under\n\t\t\t\tconditions specified by the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tpursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2", "@proposed": "true"}], "#text": "A drug or category of drugs\n\t\t\t\tthat presents demonstrable difficulties for compounding, which may include a\n\t\t\t\tcomplex dosage form or biological product, as designated by the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Drugs that are\n\t\t\t\tdemonstrably difficult to compound"}, "#text": "\n                  ", "@id": "id683580DDC0B746479134E18F294DE5FE"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ", conditionally approved under ", "@entity-type": "act", "#text": "512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": ", or included on the index established under ", "@entity-type": "act", "#text": "section\n\t\t\t\t571", "@value": "Federal Food, Drug, and Cosmetic Act/s:571"}, {"#tail": ", except as\n\t\t\t\tprovided in ", "@entity-type": "act", "#text": "section 572(a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:572/ss:a/p:1"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:3", "@proposed": "true"}], "#text": "A drug, other than a biological product, that is a copy of\n\t\t\t\ta marketed drug approved under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Marketed\n\t\t\t\tdrugs"}, "#text": "\n                  ", "@id": "id42958634B4D8402C9295EEB6A18290F9"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:4", "@proposed": "true"}, "#text": "A drug that is a biological product, except as provided\n\t\t\t\tin "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Biological\n\t\t\t\tproducts"}, "#text": "\n                  ", "@id": "idC888A8C0E6114B4C836C49FE65180E1F"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " in the Federal Register of drugs that have been withdrawn or\n\t\t\t\tremoved from the market because such drug or components of such drug have been\n\t\t\t\tfound to be unsafe or not effective, subject to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:5", "@proposed": "true"}], "#text": "A drug that appears on a list published\n\t\t\t\tby the "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Drugs removed\n\t\t\t\tfor safety and efficacy"}, "#text": "\n                  ", "@id": "ID4D0BE8B4A67348F5A3C1B494894DFDB7", "@commented": "no"}]}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "may include the\n\t\t\t\tdesignation of drugs or categories of drugs that are complex dosage forms or\n\t\t\t\tbiological products, such as extended release products, metered dose inhalers,\n\t\t\t\ttransdermal patches, and sterile liposomal products; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "idD4E81B03C4BE4C709A42E3B096EFB256", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "shall specify,\n\t\t\t\tfor each drug included on the list, whether the prohibition or condition\n\t\t\t\tapplies to the use of the drug in humans, animals, or both."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "id8C0EDC081E6E483FB8BC7D0B798A115A", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may promulgate a regulation that designates\n\t\t\t\tdrugs or categories of drugs that are demonstrably difficult to compound that\n\t\t\t\tmay not be compounded, or that may be compounded only under conditions\n\t\t\t\tspecified by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". Such regulation\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "#text": "\n                  ", "@id": "id108691FE8F4B4B638FEF8C42FB4C0BB5", "@commented": "no"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "publishing a\n\t\t\t\tnotice of such drugs proposed for designation, including the rationale for such\n\t\t\t\tdesignation, in the Federal Register;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "#text": "\n                      ", "@id": "id3F0ECA26028B42EEA4DD3ED993479558", "@commented": "no"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "providing a\n\t\t\t\tperiod of not less than 60 days for comment on the notice; and"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "#text": "\n                      ", "@id": "idEC67BA0BFA74424ABC8EDF1684DD438A", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "publishing a\n\t\t\t\tnotice in the Federal Register designating the drugs that are complex dosage\n\t\t\t\tforms and biological products that cannot be compounded."}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "#text": "\n                      ", "@id": "idEED32EC05C2D45259957852FBBBE330F", "@commented": "no"}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2/sp:A", "@proposed": "true"}, {"#tail": " may designate drugs that are complex\n\t\t\t\tdosage forms or biological products that cannot be compounded by\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Before the effective date of the regulation promulgated\n\t\t\t\tunder "}, "#text": "\n                    ", "@id": "idDBAA2EAA2749495195AA75DBA6DB6833", "@commented": "no"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": " or on the effective date of the final\n\t\t\t\tregulation under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Pharmaceutical Compounding Quality and\n\t\t\t\tAccountability Act", "@value": "Pharmaceutical Compounding Quality and Accountability Act"}, "#text": "\n                        "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall cease to have force or effect on the\n\t\t\t\tdate that is 5 years after the date of enactment of the\n\t\t\t\t", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2/sp:B/cl:i", "@proposed": "true"}, {"#tail": ", whichever is earlier.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2/sp:A", "@proposed": "true"}], "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Any\n\t\t\t\tnotice provided under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Sunset"}, "#text": "\n                    ", "@id": "id4AB88029E0A94DF6897B85CBE6478F90", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Interim\n\t\t\t\tlist"}, "#text": "\n                  ", "@id": "id884A5FC134954D8381624206B78E550C", "@commented": "no"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Drugs that are\n\t\t\t\tdemonstrably difficult to compound"}, "#text": "\n                ", "@id": "idB80B609678C84FF58C631D50C00C9092", "@commented": "no"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "@id": "id481F27E7F74145ED9732CA16C2E3069B", "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the compounded\n\t\t\t\tvariation produces for the patient a clinical difference between the compounded\n\t\t\t\tdrug and such marketed drug, as determined by the prescribing practitioner,\n\t\t\t\tand, prior to beginning compounding a variation of such drug, the facility\n\t\t\t\tcompounding the variation receives a prescription order specifying that the\n\t\t\t\tvariation may be compounded; or"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                      ", "@id": "idBC4050AD48EA4A99AD05B7BE5481B076", "@commented": "no"}, {"@indent": "up1", "#tail": "\n                  ", "enum": {"#tail": "\n                      ", "#text": "(II)"}, "item": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (in the\n\t\t\t\tcase of a human drug), on the Current Drug Shortages list for veterinary\n\t\t\t\tproducts maintained on the Internet Web site of the Food and Drug\n\t\t\t\tAdministration (in the case of an animal drug), or in the ", "@entity-type": "act", "#text": "section 506E", "@value": "Federal Food, Drug, and Cosmetic Act/s:506E"}, {"#tail": " sole\n\t\t\t\tdiscretion, has otherwise been identified by the ", "@entity-type": "federal-body", "#text": "Secretary\u2019s", "@entity-id": "7500"}, {"#tail": " as in shortage such\n\t\t\t\tas in a specific region or on a drug shortage list maintained by a private\n\t\t\t\tparty; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "such marketed drug, at\n\t\t\t\tthe time of compounding a copy of such drug and at the time of distribution of\n\t\t\t\tthe compounded drug, is on the drug shortage list under "}, "enum": {"#tail": "\n                        ", "#text": "(aa)"}, "@display-inline": "yes-display-inline", "#text": "\n                        ", "@id": "idDA7D6A8A77A04D5391073F9EDAE633AE", "@commented": "no"}, {"@indent": "up1", "#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " not later than 3 calendar days\n\t\t\t\tafter beginning the compounding, unless the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " waives the notice\n\t\t\t\trequirement; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "the traditional compounder or the\n\t\t\t\tcompounding manufacturer notifies the "}, "enum": {"#tail": "\n                        ", "#text": "(bb)"}, "#text": "\n                        ", "@id": "idCBCA5C0C21904F548F02972A8B4CA9C1", "@commented": "no"}], "#text": "\n                      ", "@id": "idA5585ADD81B9464E8DC17B3B2A50D6D5", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " that is subject to a risk evaluation\n\t\t\t\tand mitigation strategy approved with elements to assure safe use pursuant to\n\t\t\t\t", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ", the entity compounding the drug demonstrates to the ", "@entity-type": "act", "#text": "section 505\u20131", "@value": "Federal Food, Drug, and Cosmetic Act/s:505\u20131"}, {"#tail": "\n\t\t\t\tthat the entity will utilize controls that are comparable to the controls\n\t\t\t\tapplicable under the relevant risk evaluation and mitigation strategy.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "in the case of a\n\t\t\t\tmarketed drug approved under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "idC78F9D091AA04B5EA408C799FF79D653", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ", conditionally approved under\n\t\t\t\t", "@entity-type": "act", "#text": "512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": ", or included on the index established under ", "@entity-type": "act", "#text": "section 571", "@value": "Federal Food, Drug, and Cosmetic Act/s:571"}, {"#tail": ",\n\t\t\t\tincluding variations of such drug compounded from bulk substances, may be\n\t\t\t\tcompounded only if\u2014", "@entity-type": "act", "#text": "section 572(a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:572/ss:a/p:1"}], "#text": "A drug (other than a biological product) that is a copy\n\t\t\t\tof a marketed drug approved under "}, "#text": "\n                  ", "@id": "id1435EC34580D4AA79D435DB4E6E3CA18", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "section\n\t\t\t\t505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ", conditionally approved under ", "@entity-type": "act", "#text": "512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": ", or included on the index\n\t\t\t\testablished under ", "@entity-type": "act", "#text": "section 571", "@value": "Federal Food, Drug, and Cosmetic Act/s:571"}, {"#tail": ", does not make the repackaged drug a copy\n\t\t\t\tof such marketed drug.", "@entity-type": "act", "#text": "section 572(a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:572/ss:a/p:1"}], "#text": "For\n\t\t\t\tpurposes of this paragraph, repackaging a marketed drug approved under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Exclusion"}, "#text": "\n                  ", "@id": "idC9CE09412EC446449DE4AC47C5FECC91", "@commented": "no"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Exceptions\n\t\t\t\tregarding marketed drugs"}, "#text": "\n                ", "@id": "idAE5F6C00E48644F6AF3D98B7DC3034CB", "@commented": "no"}, {"#tail": "\n              ", "@id": "idD1CEF9DC91C844BC9ACA915D926723E4", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Exceptions\n\t\t\t\tregarding biological products"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A drug that is a biological product\n\t\t\t\tmay be compounded only if\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "such drug is\n\t\t\t\tcompounded from a licensed biological product and the compounding does not\n\t\t\t\tinvolve combining or mixing the licensed biological product with\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a\n\t\t\t\tbulk drug substance; or"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id3C591B4C264C425DAC97D914AB727286", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ", conditionally approved under\n\t\t\t\t", "@entity-type": "act", "#text": "512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": ", included on the index established under ", "@entity-type": "act", "#text": "section 571", "@value": "Federal Food, Drug, and Cosmetic Act/s:571"}, {"#tail": ", or\n\t\t\t\tlicensed under ", "@entity-type": "act", "#text": "section 572(a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:572/ss:a/p:1"}, {"#tail": ", unless the\n\t\t\t\tcompounding is limited to the combining, mixing, or diluting of licensed\n\t\t\t\tallergenic products; and", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "#text": "another,\n\t\t\t\tdifferent drug or drugs approved under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idA7F5A1287AD04E7DAF054323B2341831", "#text": "\n                    "}], "#text": "\n                  ", "@id": "id2A859AB582984865A8F33131508CBB0E"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "with respect to a\n\t\t\t\ttraditional compounder, the compounded biological product produces for the\n\t\t\t\tpatient a clinical difference between the compounded drug and the licensed\n\t\t\t\tbiological product, as determined by the prescribing practitioner, and, prior\n\t\t\t\tto beginning compounding such drug, the facility compounding the variation\n\t\t\t\treceives a prescription order specifying that the biological product may be\n\t\t\t\tcompounded;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "yes-display-inline", "#text": "\n                    ", "@id": "id5A8EC86B74A74A318890D21DB356524B", "@commented": "no"}, {"@indent": "up1", "#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "with respect to a compounding\n\t\t\t\tmanufacturer, the compounded variation biological product produces for the\n\t\t\t\tpatient a clinical difference between the compounded drug and the licensed\n\t\t\t\tbiological product, as determined by a licensed practitioner responsible for\n\t\t\t\tthe patient\u2019s care in a health care entity that provides medical services\n\t\t\t\tthrough licensed prescribers directly to patients, and, prior to beginning\n\t\t\t\tcompounding such drug, the compounding manufacturer receives a duly authorized\n\t\t\t\tmedical order from a hospital or health system specifying that the biological\n\t\t\t\tproduct may be compounded; or"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "id74F93AC177524B08AC8CE4FC00E8F06A"}, {"@indent": "up1", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the compounded biological product\n\t\t\t\tis an allergenic product."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "#text": "\n                    ", "@id": "id96F80EB163844D9DB6740CA1C6E171FE"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id86A28F6A8F054D1E906D7A2950ED88BD", "#text": "\n                  "}], "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " in the Federal Register of drugs that have been withdrawn or\n\t\t\t\tremoved from the market, as described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall specify\n\t\t\t\twhether a human drug on such list may, notwithstanding the inclusion on such\n\t\t\t\tlist, be compounded for use in animals. The ", "@entity-type": "act", "#text": "paragraph (1)(D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:1/sp:D", "@proposed": "true"}, {"#tail": " shall update the lists\n\t\t\t\tdescribed in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "subparagraphs (D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:2/sp:D", "@proposed": "true"}, {"#tail": ", as appropriate, to\n\t\t\t\tconform with the list described in ", "@entity-type": "act", "#text": "(E) of subsection (e)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:2/sp:E", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)(D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:1/sp:D", "@proposed": "true"}], "#text": "The list published\n\t\t\t\tby the "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Requirement\n\t\t\t\tregarding drugs removed for safety or efficacy"}, "#text": "\n                ", "@id": "id1E712E3DB5BC4E65B65A6DE69E770416", "@commented": "no"}], "#text": "\n              ", "@id": "id9D65C932308C4CA1A4DAE9CED5164DDD"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Quality of drug\n\t\t\t\tingredients"}, "paragraph": [{"#tail": "\n              ", "@id": "idA3C6AB0C1CA54DA3BEB491EDDDD3B666", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Human\n\t\t\t\tdrugs"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A traditional compounder or a compounding manufacturer\n\t\t\t\tshall\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " published at ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "compound a human\n\t\t\t\tdrug using only bulk drug substances (as defined in regulations of the\n\t\t\t\t", "external-xref": {"#tail": " of title 21, Code of Federal\n\t\t\t\tRegulations (or any successor regulations))\u2014", "@parsable-cite": "usc/21/207", "#text": "section 207.3(a)(4)", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "that\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", and the United States Pharmacopoeia chapters on pharmacy\n\t\t\t\tcompounding;", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(6)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:6", "@proposed": "true"}, "#text": "comply with the\n\t\t\t\tstandards of an applicable United States Pharmacopoeia or National Formulary\n\t\t\t\tmonograph, if a monograph exists and has not been identified under "}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "IDE6DB70F8D2A54DC1952C2CDBBA04AF4A", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "if such a\n\t\t\t\tmonograph does not exist, are drug substances that are components of drugs\n\t\t\t\tapproved by the "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "ID1EBD4FC4F6EF429AA3F850E0891BB835", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", that appear on a list developed by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tthrough regulations issued by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ";", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "if such a\n\t\t\t\tmonograph does not exist and the drug substance is not a component of a drug\n\t\t\t\tapproved by the "}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "IDFF52C6DC676C4B57A3258D1CFF2A40F8", "#text": "\n                      "}], "#text": "\n                    ", "@id": "IDF12B697D3B224CCBA5BEF3D5BE77E849"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\t(including a foreign establishment that is registered under ", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, {"#tail": ");\n\t\t\t\tand", "@entity-type": "act", "#text": "section 510(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:510/ss:i"}], "#text": "that are\n\t\t\t\tmanufactured by an establishment that is registered under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "IDA448CA33D2F74776B6E3669191AB75F5", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "that are\n\t\t\t\taccompanied by valid certificates of analysis for each specific lot of bulk\n\t\t\t\tdrug substance; and"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "ID4305EDCEBF7244C0885A94C2253A43EA", "#text": "\n                    "}], "#text": "\n                  ", "@id": "ID9C11ECEE5FA74D05A77BAAAEA173503E"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", and with the\n\t\t\t\tUnited States Pharmacopoeia chapter on pharmacy compounding.", "@entity-type": "act", "#text": "paragraph (6)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:6", "@proposed": "true"}, "#text": "use ingredients\n\t\t\t\t(other than bulk drug substances) that comply with the standards of an\n\t\t\t\tapplicable United States Pharmacopoeia or National Formulary monograph, if a\n\t\t\t\tmonograph exists and has not been identified under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "IDA7E2C87F84C7458B92DF996A79E56BCE", "@commented": "no"}]}, {"#tail": "\n              ", "@id": "id62D837E76DF74F37864249856A72A773", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Animal\n\t\t\t\tdrugs"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A traditional compounder or a compounding manufacturer\n\t\t\t\tshall\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "compound an\n\t\t\t\tanimal drug using only bulk drug substances (as defined in regulations of the\n\t\t\t\tSecretary published at ", "external-xref": {"#tail": " of title 21, Code of Federal\n\t\t\t\tRegulations (or any successor regulations)) that\u2014", "@parsable-cite": "usc/21/207", "#text": "section 207.3(a)(4)", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (including a foreign\n\t\t\t\testablishment that is registered under ", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, {"#tail": "); and", "@entity-type": "act", "#text": "section 510(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:510/ss:i"}], "#text": "are manufactured\n\t\t\t\tby an establishment that is registered under "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id5e47029fde46483395e9bde38852695d", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "are accompanied\n\t\t\t\tby valid certificates of analysis for each specific lot of bulk drug\n\t\t\t\tsubstance;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idbb3e48471d20427d94a0e9af96fefbb6", "#text": "\n                    "}], "#text": "\n                  ", "@id": "ide98f91f0616f40bcac33fe596184c29e"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", and with the\n\t\t\t\tUnited States Pharmacopoeia chapters on pharmacy compounding;", "@entity-type": "act", "#text": "paragraph (6)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:6", "@proposed": "true"}, "#text": "use ingredients\n\t\t\t\t(other than bulk drug substances) that comply with the standards of an\n\t\t\t\tapplicable United States Pharmacopoeia or National Formulary monograph, if a\n\t\t\t\tmonograph exists and has not been identified under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idA7F55762CD6D44D19C91579496485B85", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\tcompounded animal drug for use in non-food-producing minor species, use bulk\n\t\t\t\tsubstances that\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", and with the United States Pharmacopoeia chapters on pharmacy\n\t\t\t\tcompounding;", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(6)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:6", "@proposed": "true"}, "#text": "comply with the\n\t\t\t\tstandards of an applicable United States Pharmacopoeia or National Formulary\n\t\t\t\tmonograph, if a monograph exists and has not been identified under "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idbc72f4ddd9ae497e8eac1cc6faba8d2c", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "if such a\n\t\t\t\tmonograph does not exist, are drug substances that are components of drugs\n\t\t\t\tapproved by the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id44b69f6dc5ba49a08d5bcecdb00cbdcd", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", that appear on a list developed by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tthrough regulations issued by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ";", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "if such a\n\t\t\t\tmonograph does not exist and the drug substance is not a component of a drug\n\t\t\t\tapproved by the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id10227604a6e34c768e005a8dc8521eee", "#text": "\n                    "}], "#text": "\n                  ", "@id": "id7627130DE7A04EF5B9669617BB4EEC67"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", shall use bulk substances that are included on such list, subject to\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(3)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:3/sp:A", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "act", "#text": "paragraph (3)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:3/sp:C", "@proposed": "true"}], "#text": "in the case of a\n\t\t\t\tcompounded animal drug for use in non-food-producing major species, beginning\n\t\t\t\ton the date of publication of the list established in accordance with "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "idA3E265515E3E4430B6C2AF2A8534FF0B", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " of\n\t\t\t\tbulk substances acceptable for use in compounding a drug for one or more such\n\t\t\t\tspecies, in accordance with ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:4", "@proposed": "true"}], "#text": "in the case of a\n\t\t\t\tcompounded animal drug for use in food-producing major and minor species, shall\n\t\t\t\tuse bulk substances that are included on a list established by the "}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "id7D5ECD0B44E546DFBEC16F5684AEAD70", "#text": "\n                  "}], "@commented": "no"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "text": {"short-title": {"#tail": ", the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Pharmaceutical Compounding Quality and\n\t\t\t\tAccountability Act", "@value": "Pharmaceutical Compounding Quality and Accountability Act", "@proposed": "true"}, "#text": "\n                      "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish a list of bulk\n\t\t\t\tsubstances acceptable for compounding a drug for use in non-food-producing\n\t\t\t\tmajor species, and any conditions applicable to such use, and may also identify\n\t\t\t\tbulk substances that the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " has determined not acceptable for\n\t\t\t\tcompounding with respect to a drug for use in such species.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Not later than 30 days after the effective date of the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "id004D2BC59D9844C98CC8B27705FCD8A5"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "publish a notice\n\t\t\t\tin the Federal Register identifying bulk substances proposed as acceptable and\n\t\t\t\tany bulk substance determine to be unacceptable, and the rationale for such\n\t\t\t\tproposed designations;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idd12c0692831a4c50a37301967fc92f57", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "provide a period\n\t\t\t\tof not less than 30 days for comment on the notice; and"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id44af568875364a04a4b47e785f8a588b", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "publish a\n\t\t\t\tnotice in the Federal Register designating the bulk substances acceptable, and\n\t\t\t\tany bulk substances determined to be unacceptable, and the rationale for such\n\t\t\t\tdesignations and determinations."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "idad200469d99a40ea929c39c041b17f6a", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Procedure"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:3/sp:A", "@proposed": "true"}, {"#tail": "\n\t\t\t\tshall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In\n\t\t\t\tdeveloping and updating the list under "}, "#text": "\n                  ", "@id": "id7F9E5FD1328D43F3857518F907299572"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", any traditional\n\t\t\t\tcompounder or compounding manufacturer that has received and filled a\n\t\t\t\tprescription in the 60 days prior to such publication for a compounded drug for\n\t\t\t\ta non-food-producing major species from a bulk substance not addressed in the\n\t\t\t\tnotice (either as acceptable or unacceptable), and that reasonably expect to\n\t\t\t\treceive and fill another prescription for such a drug for such species within\n\t\t\t\t60 days after such publication, may notify the ", "@entity-type": "act", "#text": "subparagraph (B)(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:3/sp:B/cl:iii", "@proposed": "true"}, {"#tail": " of such bulk substance\n\t\t\t\twithin 30 days of such publication, in a manner to be determined by the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and published in the Federal Register on or before publication of the\n\t\t\t\tlist under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". A traditional compounder or compounding\n\t\t\t\tmanufacturer that provides such notice shall not be subject to the restriction\n\t\t\t\tin ", "@entity-type": "act", "#text": "subparagraph (B)(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:3/sp:B/cl:iii", "@proposed": "true"}, {"#tail": " until such time as the ", "@entity-type": "act", "#text": "paragraph (2)(D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:2/sp:D", "@proposed": "true"}, {"#tail": " designates such bulk\n\t\t\t\tsubstance as acceptable or determines it to be unacceptable pursuant to the\n\t\t\t\tprocess described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (B)(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:3/sp:B/cl:iii", "@proposed": "true"}], "#text": "Upon\n\t\t\t\tinitial publication of the list under "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Notification"}, "#text": "\n                  ", "@id": "id622C237CC1C74E51AB1A95F4183B7E3F"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may amend the list at any time, in accordance\n\t\t\t\twith process described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:3/sp:B", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Modification of\n\t\t\t\tlist"}, "#text": "\n                  ", "@id": "id4DE045D882034AB78D3FA14A8A43C5DB"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the safety of the\n\t\t\t\tbulk substance;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idF11E00CC063543EFA45AF5E0E1E29753", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "historical use\n\t\t\t\tof the substance in pharmacy compounding;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idF041EFC729D04D29B6228C51720B58BD", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "evidence of the\n\t\t\t\teffectiveness of the bulk substance or lack of effectiveness;"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id8FEB07A930924B1782608F7334DE464C", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ", conditionally approved under ", "@entity-type": "act", "#text": "512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": ", or\n\t\t\t\tincluded on the index established under ", "@entity-type": "act", "#text": "section 571", "@value": "Federal Food, Drug, and Cosmetic Act/s:571"}, {"#tail": ", can be used on\n\t\t\t\tlabel, or any drug approved under ", "@entity-type": "act", "#text": "section 572(a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:572/ss:a/p:1"}, {"#tail": " or ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " can be used in an\n\t\t\t\textralabel manner in accordance with section ", "@entity-type": "act", "#text": "512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": " and ", "@entity-type": "act", "#text": "paragraphs (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:a/p:4"}, {"#tail": ", to treat the applicable condition in the identified species; and", "@entity-type": "act", "#text": "(5) of section\n\t\t\t\t512(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:a/p:5"}], "#text": "whether any drug\n\t\t\t\tapproved under "}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "@id": "idC88B6BD87AB24B829C906E5A64B2B46F", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ",\n\t\t\t\tconditionally approved under ", "@entity-type": "act", "#text": "512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": ", or included on the index established\n\t\t\t\tunder ", "@entity-type": "act", "#text": "section 571", "@value": "Federal Food, Drug, and Cosmetic Act/s:571"}, {"#tail": ".", "@entity-type": "act", "#text": "section 572(a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:572/ss:a/p:1"}], "#text": "whether a\n\t\t\t\tcompounded drug appropriate to treat the applicable condition in the identified\n\t\t\t\tspecies could be obtained by manipulating a drug approved under "}, "enum": {"#tail": "\n                    ", "#text": "(v)"}, "@id": "idF8DDA96C109042E6BEECCB640FB72059", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Criteria"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:3/sp:B", "@proposed": "true"}, {"#tail": "\n\t\t\t\tshall consider, among other factors\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In\n\t\t\t\tevaluating bulk substances for purposes of "}, "#text": "\n                  ", "@id": "idDBDE253FC8EC413D87062F90BC8F8900"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Non-food-producing\n\t\t\t\tmajor species listing procedure"}, "#text": "\n                ", "@id": "id673AA966C9BF4178B96C4BDE470F64BF"}, {"#tail": "\n              ", "@id": "id18519C3B3CBB40ECA5017CC7DC8FB05C", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Food-producing\n\t\t\t\tanimals listing procedure"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and any conditions\n\t\t\t\tapplicable to such use, the ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:2", "@proposed": "true"}, {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In establishing a list of designated\n\t\t\t\tbulk substances acceptable for use in compounding a drug for use in\n\t\t\t\tfood-producing major and minor species under "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish a notice\n\t\t\t\tin the Federal Register identifying bulk substances proposed as acceptable and\n\t\t\t\tany bulk substance determine to be unacceptable, and the rationale for such\n\t\t\t\tdesignations;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idb45c14775a4c4b6e8a44217c2f3281f2", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide a period\n\t\t\t\tof not less than 30 days for comment on the notice; and"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idbae007c8dd8f4136a816e0ced5e7015e", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish a notice\n\t\t\t\tin the Federal Register designating the bulk substances acceptable for use in\n\t\t\t\tcompounding a drug for use in food-producing major and minor species, and the\n\t\t\t\trationale for such designations."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id699a226e70714e8ba780994437cf0464", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The requirements for establishing substantially extended\n\t\t\t\twithdrawal periods in accordance with ", "external-xref": {"#tail": " of title 21, Code of\n\t\t\t\tFederal Regulations (or any successor regulations) shall apply to compounded\n\t\t\t\tanimal drugs for use in food-producing animals that are compounded using bulk\n\t\t\t\tsubstances.", "@parsable-cite": "usc/21/530", "#text": "section 530.20", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Withdrawal\n\t\t\t\tperiods"}, "#text": "\n                ", "@id": "id5311468C28574984811043E6FE21D981"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "subparagraph (A)(i)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:1/sp:A/cl:i/scl:I", "@proposed": "true"}, {"#tail": " or ", "@entity-type": "act", "#text": "(B) of paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:1/sp:B", "@proposed": "true"}, {"#tail": " or\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:2/sp:B", "@proposed": "true"}, {"#tail": ", the ", "@entity-type": "act", "#text": "(C)(i) of paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:2/sp:C/cl:i", "@proposed": "true"}, {"#tail": " may identify bulk substances that the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " determines, based on public health concerns, may not be used in\n\t\t\t\tcompounding a drug.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Notwithstanding the existence of an applicable monograph\n\t\t\t\tunder "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "idA27167AA14C344389AAA91A445F0E19E"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "publish a notice\n\t\t\t\tof such bulk substances proposed for identification in the Federal\n\t\t\t\tRegister;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "id4F4212AF65034BB0ABE1A10C7FB4AD36", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "provide a period\n\t\t\t\tof not less than 60 days for comment on the notice;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "idC6F3633DF918423CB0628ED6B990E737", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "publish a\n\t\t\t\tnotice in the Federal Register identifying the bulk substances that may not be\n\t\t\t\tused in compounding a drug; and"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "#text": "\n                    ", "@id": "id771C4790F4684DB1988022FBB5E8AD05", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "state whether\n\t\t\t\tthe bulk is not suitable for compounding of human drugs, animal drugs, or\n\t\t\t\tboth."}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "#text": "\n                    ", "@id": "id08A3C0901DF4453498566126140B5AA3", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Procedure"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "In\n\t\t\t\tidentifying the bulk substances that may not be used in compounding, the\n\t\t\t\t"}, "#text": "\n                  ", "@id": "id4ECF80E150574AFE82373EAE986918E8"}], "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Identification\n\t\t\t\tby Secretary\n                "}, "#text": "\n                ", "@id": "idC87C9E923A764B03B72468AF698F91A0"}], "#text": "\n              ", "@id": "idA26C9E119AB94D0E9C4EF67BEF7A6D47"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Requirements\n\t\t\t\tregarding wholesaling and labeling applicable to traditional compounders and\n\t\t\t\tcompounding manufacturers"}, "paragraph": [{"#tail": "\n              ", "@id": "id8667B99A4DA343CEA0421944645963DD", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A compounded drug\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "may not be sold\n\t\t\t\tby an entity other than the compounding manufacturer or traditional compounder\n\t\t\t\tthat compounded the drug;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id9F80D551B3A9442CAF67B62CDF7A5B60", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "compounded by a\n\t\t\t\tcompounding manufacturer may not be sold to an entity other than a health care\n\t\t\t\tentity that provides medical services through licensed prescribers directly to\n\t\t\t\tpatients or animals, or a network of such providers, except that a compounding\n\t\t\t\tmanufacturer may transfer without profit a compounded sterile drug to a\n\t\t\t\tlicensed pharmacy if\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the licensed\n\t\t\t\tpharmacy falls under the same corporate ownership as the compounding\n\t\t\t\tmanufacturer;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id32ED1352EB75411FB553D462098CC8C8", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the transfer of\n\t\t\t\tsuch compounded sterile drug is solely for the purpose of dispensing the\n\t\t\t\tcompounded sterile drug to the end user, who has been instructed by the\n\t\t\t\tprescribing physician to self-administer such compounded sterile drug;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id7611569AED0E4920B40A1786D70876CC", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"short-title": {"#tail": ", the compounding\n\t\t\t\tmanufacturer is an entity that provides pharmacy benefits management services\n\t\t\t\ton behalf of a health benefits plan;", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Pharmaceutical\n\t\t\t\tCompounding Quality and Accountability Act", "@value": "Pharmaceutical Compounding Quality and Accountability Act", "@proposed": "true"}, "#text": "\n                        "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "as of the date\n\t\t\t\tof enactment of the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "idBE87C394F3DE4C9BBC4698CD7F3B54F2", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"short-title": {"#tail": ", in a manner described\n\t\t\t\tby the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Pharmaceutical\n\t\t\t\tCompounding Quality and Accountability Act", "@value": "Pharmaceutical Compounding Quality and Accountability Act", "@proposed": "true"}, "#text": "\n                        "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " upon registering under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " as an entity that qualifies for the exemption under this\n\t\t\t\tsubparagraph, and provides documentation of the compounding of such drugs as of\n\t\t\t\tthe date of enactment of the ", "@entity-type": "act", "#text": "subsection (g)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:2", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the compounding\n\t\t\t\tmanufacturer identifies itself to the "}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "@id": "ide819637ff124446ab94e9f5b32db9405", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that the compounding\n\t\t\t\tmanufacturer qualifies for the exemption under this subparagraph and the\n\t\t\t\tsterile drug or drugs for which the exemption applies; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the compounding\n\t\t\t\tmanufacturer receives confirmation from the "}, "enum": {"#tail": "\n                    ", "#text": "(v)"}, "@id": "id35a232a12b4042a8ba02f85b53dc5a5e", "#text": "\n                    "}], "#text": "\n                  ", "@id": "id1454cdb6d39d480c880ae4f5aaae5834"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",\n\t\t\t\tshall be labeled ", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:f/p:1/sp:B", "@proposed": "true"}, "#text": "in the case of a\n\t\t\t\tcompounded drug sold to a health care entity described in ", "quote": {"#tail": ".", "#text": "not for resale"}}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id007EBD3399A5440F8659169170BC4216", "#text": "\n                  "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The advertising and promotion of compounded drugs shall\n\t\t\t\tnot be false or misleading in any particular."}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Advertising and\n\t\t\t\tpromotion"}, "#text": "\n                ", "@id": "id72B54F427E5B4FF690CCA027A388E2DE"}], "#text": "\n              ", "@id": "id833A2EC3FBFE468B8D50C90196E09D5E"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Other\n\t\t\t\trequirements applicable to compounding manufacturers"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "A compounding manufacturer shall ensure that\n\t\t\t\ta pharmacist licensed in the State where the compounding manufacturer is\n\t\t\t\tlocated exercises direct supervision over the operations of the compounding\n\t\t\t\tmanufacturer."}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Licensed\n\t\t\t\tpharmacist oversight"}, "#text": "\n                ", "@id": "idC2C2F2F332384A32B1F3F961DCA27047"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " its name, place of business, and unique facility identifier (which\n\t\t\t\tshall conform to the requirements for the unique facility identifier\n\t\t\t\testablished under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "), and a point of contact e-mail address.", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}], "#text": "During the period beginning on October 1 and ending\n\t\t\t\ton December 31 each year, each compounding manufacturer shall register with the\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Annual\n\t\t\t\tregistration"}, "#text": "\n                    ", "@id": "id55D2A2BD15664785B3156A02208583E0"}, {"#tail": "\n                  ", "text": {"short-title": {"#tail": ". In no case may registration be required until\n\t\t\t\tat least 60 days following publication of the timeline in the Federal\n\t\t\t\tRegister.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Pharmaceutical Compounding Quality and\n\t\t\t\tAccountability Act", "@value": "Pharmaceutical Compounding Quality and Accountability Act", "@proposed": "true"}, "#text": "\n                        "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", shall\n\t\t\t\timmediately register with the ", "@entity-type": "act", "#text": "subsection (b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1", "@proposed": "true"}, {"#tail": " and provide the information described\n\t\t\t\tunder ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". The ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:2/sp:A/cl:i", "@proposed": "true"}, {"#tail": " shall establish a timeline for registration for\n\t\t\t\tthe first year following the effective date of the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each compounding manufacturer, upon\n\t\t\t\tfirst engaging in the operations described in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "New\n\t\t\t\tcompounding manufacturers"}, "#text": "\n                    ", "@id": "id4D1E5A1E60F84FCC9BB2069CA196916D"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "clauses (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:2/sp:A/cl:i", "@proposed": "true"}, {"#tail": " shall immediately identify to the\n\t\t\t\t", "@entity-type": "act", "#text": "(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, {"#tail": " any additional facility that engages in the activities described in\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and that is owned or operated in any State by the person that\n\t\t\t\towns or operates the compounding manufacturer.", "@entity-type": "act", "#text": "subsection (b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1", "@proposed": "true"}], "#text": "Each compounding manufacturer duly registered in\n\t\t\t\taccordance with "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Additional\n\t\t\t\tfacilities"}, "#text": "\n                    ", "@id": "idF12E4B8D32A34B56ADDA893692F47877"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make available\n\t\t\t\tfor inspection, to any person so requesting, any registration filed pursuant to\n\t\t\t\tthis subparagraph, except that any drug reporting information submitted\n\t\t\t\tpursuant to this subparagraph and the information accompanying such reporting\n\t\t\t\tshall be exempt from such inspection, unless the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " finds that such an\n\t\t\t\texemption would be inconsistent with the protection of the public\n\t\t\t\thealth.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "header": {"#tail": "\n                    ", "#text": "Availability\n\t\t\t\tof registration for inspection"}, "#text": "\n                    ", "@id": "idE6108384DC254E90AF11B6F2A04A5B9E"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Registration of\n\t\t\t\tcompounding manufacturers"}, "#text": "\n                  ", "@id": "id421F01E533DE4C6495C4A8BB825D3957"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "identifying the\n\t\t\t\tdrugs compounded by such compounding manufacturer during the previous 6-month\n\t\t\t\tperiod; and"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "id4E491B24598F408F97A107C169C65C20", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", providing the active ingredient, the\n\t\t\t\tsource of such active ingredient, the National Drug Code number of the source\n\t\t\t\tdrug or bulk active ingredient, the strength of the active ingredient per unit,\n\t\t\t\tthe dosage form and route of administration, the package description, the\n\t\t\t\tnumber of individual units produced, the National Drug Code number of the final\n\t\t\t\tproduct, and which conforms to other applicable requirements identified by the\n\t\t\t\t", "@entity-type": "act", "#text": "subclause (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:2/sp:B/cl:i/scl:I", "@proposed": "true"}, {"#tail": " in accordance with ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:2/sp:B/cl:ii", "@proposed": "true"}], "#text": "with respect to\n\t\t\t\teach drug identified under "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "id9E178B7CEB35439B8523C2F5EDF28D60", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall submit to the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:2/sp:A", "@proposed": "true"}, {"#tail": ", once during the\n\t\t\t\tmonth of June of each year and once during the month of December of each year,\n\t\t\t\ta report\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Each com\u00adpound\u00ading manufacturer who registers with the\n\t\t\t\t"}, "#text": "\n                    ", "@id": "id79D78C95B30443CD97CCF7889C7A1704"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be prepared in such form and manner as the\n\t\t\t\t", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:2/sp:B/cl:i", "@proposed": "true"}, {"#tail": " may prescribe by regulation or guidance.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Each\n\t\t\t\treport under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Form"}, "#text": "\n                    ", "@id": "idF983F6DC1A4241C998F39FCDE54F619C"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Drug reporting\n\t\t\t\tby compounding manufacturers"}, "#text": "\n                  ", "@id": "id2BDD2002550E4AEF8E20F578EBCFD917"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " by electronic means unless the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " grants a\n\t\t\t\trequest for waiver of such requirement because use of electronic means is not\n\t\t\t\treasonable for the person requesting waiver.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Registrations and drug reporting under\n\t\t\t\tthis paragraph (including the submission of updated information) shall be\n\t\t\t\tsubmitted to the "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Electronic\n\t\t\t\tregistration and reporting"}, "#text": "\n                  ", "@id": "id76AA4E93AED944B88336D10189BE2A80"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 704", "@value": "Federal Food, Drug, and Cosmetic Act/s:704"}, "#text": "Compounding manufacturers shall be subject to inspection\n\t\t\t\tpursuant to "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "id6A6A6D7936F44888910435CA0A2AB587"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through one or more officers or\n\t\t\t\temployees duly designated by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall inspect compounding\n\t\t\t\tmanufacturers described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in accordance with a risk-based schedule\n\t\t\t\testablished by the ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:2/sp:D/cl:i", "@proposed": "true"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Risk-based\n\t\t\t\tschedule"}, "#text": "\n                    ", "@id": "id95FC98A78AD34CCBAF3BE86B12A0DB0B"}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The compliance\n\t\t\t\thistory of the compounding manufacturer."}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "iddf7ad7d8bca24352a6c54bda15d6b340", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The record,\n\t\t\t\thistory, and nature of recalls linked to the compounding manufacturer."}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "id669be2a27d274711abde0fd3d7fa5925", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The inherent\n\t\t\t\trisk of the drug compounded at the compounding manufacturer."}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "ideee744146b644e7faf6bf099a7f18545", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " within the\n\t\t\t\tlast 4 years.", "@entity-type": "act", "#text": "section 704", "@value": "Federal Food, Drug, and Cosmetic Act/s:704"}, "#text": "The inspection\n\t\t\t\tfrequency and history of the compounding manufacturer, including whether the\n\t\t\t\tcompounding manufacturer has been inspected pursuant to "}, "enum": {"#tail": "\n                      ", "#text": "(IV)"}, "@id": "id5333a41d04664e27bcc45d90140e353b", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for purposes of\n\t\t\t\tallocating inspection resources.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Any other\n\t\t\t\tcriteria deemed necessary and appropriate by the "}, "enum": {"#tail": "\n                      ", "#text": "(V)"}, "@id": "idfff4cdba7e524939a1f5515718d1a032", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Risk\n\t\t\t\tfactors"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "clause\n\t\t\t\t(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:2/sp:D/cl:ii", "@proposed": "true"}, {"#tail": " shall inspect compounding manufacturers according to the\n\t\t\t\tknown safety risks of such compounding manufacturers, which shall be based on\n\t\t\t\tthe following factors:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In establishing the risk-based schedule under "}, "#text": "\n                    ", "@id": "id0A044EC7F35A42B8B438B9F7F2950F87"}], "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Risk-based\n\t\t\t\tinspection frequency"}, "#text": "\n                  ", "@id": "id1A157CED2E5E4E738F515EB1065B7CE0"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Registration of\n\t\t\t\tcompounding manufacturers and reporting of drugs"}, "#text": "\n                ", "@id": "id66BFC03B77664C5BA2C3C84B37514540"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "an event\n\t\t\t\toccurring in the course of the use of the drug in professional practice;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "idBDF4A3435B704D018BED4DD4D018DF82", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "an event\n\t\t\t\toccurring from an overdose of the drug, whether accidental or\n\t\t\t\tintentional;"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "idF1290E15DB084AF0958FDE6E547CAF28", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "an event\n\t\t\t\toccurring from abuse of the drug;"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "idB5E137513FF845BA83B442E3D90E7B3F", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "an event\n\t\t\t\toccurring from withdrawal of the drug; and"}, "enum": {"#tail": "\n                      ", "#text": "(IV)"}, "@id": "id0EDE3AE2211F45C7A4DEA30C4744231F", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "any failure of\n\t\t\t\texpected pharmacological action of the drug."}, "enum": {"#tail": "\n                      ", "#text": "(V)"}, "@id": "id6CB54B1422254B769A931A8B0C53B3AF", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Adverse\n\t\t\t\tevent"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means any\n\t\t\t\thealth-related event associated with the use of a compounded drug that is\n\t\t\t\tadverse, including\u2014", "#text": "adverse event"}, "#text": "The term "}, "#text": "\n                    ", "@id": "idD6C72C0E69244B5C80B2ADA097A5ACD2"}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "results\n\t\t\t\tin\u2014"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "item": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "death;"}, "enum": {"#tail": "\n                        ", "#text": "(aa)"}, "@id": "id707F247BC508464498B73C16CBEF99C7", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "an\n\t\t\t\tadverse drug event that places the patient at immediate risk of death from the\n\t\t\t\tadverse drug event as it occurred (not including an adverse drug event that\n\t\t\t\tmight have caused death had it occurred in a more severe form);"}, "enum": {"#tail": "\n                        ", "#text": "(bb)"}, "@id": "id67D5890F9EE440FF94259B5DBAA8D596", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "inpatient\n\t\t\t\thospitalization or prolongation of existing hospitalization;"}, "enum": {"#tail": "\n                        ", "#text": "(cc)"}, "@id": "idFD5AA951FD1549E090DF2ECF24838530", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "a\n\t\t\t\tpersistent or significant incapacity or substantial disruption of the ability\n\t\t\t\tto conduct normal life functions; or"}, "enum": {"#tail": "\n                        ", "#text": "(dd)"}, "@id": "id7502DCE8F78647CE973914EE20D4A85A", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "a\n\t\t\t\tcongenital anomaly or birth defect; or"}, "enum": {"#tail": "\n                        ", "#text": "(ee)"}, "@id": "id7BF02EF5275841AABC502E9BC101331C", "#text": "\n                        "}], "#text": "\n                      ", "@id": "idC27D838102D545148AA12428BFCDDE59"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subclause\n\t\t\t\t(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:3/sp:A/cl:ii/scl:I", "@proposed": "true"}, "#text": "based on\n\t\t\t\tappropriate medical judgment, may jeopardize the patient and may require a\n\t\t\t\tmedical or surgical intervention to prevent an outcome described in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "id9A4C9B9A971046D0B70BE7F59BF3E854", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Serious\n\t\t\t\tadverse event"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means\n\t\t\t\tan adverse event that\u2014", "#text": "serious adverse event"}, "#text": "The term "}, "#text": "\n                    ", "@id": "id709065EB47584C41AE8C186A1A0B2E1F"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Definitions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis paragraph:"}, "#text": "\n                  ", "@id": "idB9E1BC71ACC04D8BB89AC89AF587F7A2"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as soon as practicable, but in no case later than 15 calendar days\n\t\t\t\tafter the initial receipt of the applicable information. Such manufacturer\n\t\t\t\tshall investigate and submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " followup reports for each such\n\t\t\t\tinstance not later than 15 calendar days after receipt of new information or as\n\t\t\t\trequested by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". Unless and until the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " establishes the\n\t\t\t\tcontent and format of adverse event reports by guidance or regulation, reports\n\t\t\t\tshall be submitted in accordance with the content and format requirements under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If a compounding manufacturer becomes aware of any serious\n\t\t\t\tadverse event, such manufacturer shall submit reports of each instance to the\n\t\t\t\t", "external-xref": [{"#tail": " of title 21, Code of Federal Regulations (or any successor\n\t\t\t\tregulations) (in the case of human drugs), ", "@parsable-cite": "cfr/21/310.305", "#text": "section 310.305", "@legal-doc": "regulation"}, {"#tail": " of title 21, Code of\n\t\t\t\tFederal Regulations (or any successor regulations) (in the case of biological\n\t\t\t\tproducts), or ", "@parsable-cite": "usc/21/600", "#text": "section 600.80", "@legal-doc": "usc"}, {"#tail": " of title 21, Code of Federal Regulations (or any\n\t\t\t\tsuccessor regulations) (in the case of animal drugs).", "@parsable-cite": "cfr/21/514.80", "#text": "section 514.80", "@legal-doc": "regulation"}]}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "header": {"#tail": "\n                      ", "#text": "15-day\n\t\t\t\treport"}, "#text": "\n                      ", "@id": "idA887D231F05345EC90B0D51406572265"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", including a history of\n\t\t\t\tactions taken during the year because of each report, using the content,\n\t\t\t\tformat, and manner established by the ", "@entity-type": "act", "#text": "subclause (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:3/sp:B/cl:i/scl:I", "@proposed": "true"}, {"#tail": " by guidance or regulation.\n\t\t\t\tUntil such time as the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " publishes such guidance or regulation, each\n\t\t\t\tcompounding manufacturer shall retain such summaries as part of the records to\n\t\t\t\tbe maintained in accordance with ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:3/sp:C", "@proposed": "true"}], "#text": "Compounding manufacturers that report serious adverse\n\t\t\t\tevents shall submit in December of each year a narrative summary of any\n\t\t\t\tanalysis of each report submitted under "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "header": {"#tail": "\n                      ", "#text": "Annual\n\t\t\t\treport"}, "#text": "\n                      ", "@id": "id9B633185565A4948A6368D616B7887C3"}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Adverse event\n\t\t\t\treporting requirement"}, "#text": "\n                    ", "@id": "id67869B18A5034A44A677FC89C2B0C6CF"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " a product quality report, in a form and manner established by the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " by guidance or regulation.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Not later than 3 calendar days\n\t\t\t\tafter the compounding manufacturer becomes aware of information pertaining to\n\t\t\t\tsterility, stability, or other product quality concerns that could result in\n\t\t\t\tserious adverse events, the compounding manufacturer shall submit to the\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Product\n\t\t\t\tquality reporting requirement"}, "#text": "\n                    ", "@id": "id6D321165B54A4077BDFA7E5A6604A8C6", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Reports"}, "#text": "\n                  ", "@id": "id0C33697C3DA74047B5F12E0E1AA3FC13"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in regulations.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "A compounding manufacturer shall maintain for a period of\n\t\t\t\t10 years records of all serious adverse drug events known to the compound\n\t\t\t\tmanufacturer in accordance with ", "external-xref": {"#tail": " of title 21, Code of Federal\n\t\t\t\tRegulations (or any successor regulation), or as otherwise directed by the\n\t\t\t\t", "@parsable-cite": "usc/21/314", "#text": "section 314.80(i)", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Maintenance of\n\t\t\t\trecords"}, "#text": "\n                  ", "@id": "id44536B0037694181B0485E6C23AB0067"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Adverse event\n\t\t\t\treporting"}, "#text": "\n                ", "@id": "id9537AC2124CD44C99DE9A3E16EF9CD9B"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "quote": {"#tail": " or a reasonable comparable\n\t\t\t\talternative statement (as specified by the ", "#text": "This is a compounded drug."}, "#text": "the statement\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ") that identifies the drug\n\t\t\t\tas a compounded drug;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idF9E7F797F950465EB7274D7887D5F8E3", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the name,\n\t\t\t\taddress, and phone number of the applicable compounding manufacturer;\n\t\t\t\tand"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idEB7899A57B684FA79D17102976B10755", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "with respect to\n\t\t\t\tthe compounded drug\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the lot or batch\n\t\t\t\tnumber;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "id62F76063D1DC4B87B46BD6271B486168", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the established\n\t\t\t\tname of the medication;"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "idC016A9A56CF541FCAADB648774474679", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the dosage form\n\t\t\t\tand strength;"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "idD549A01C9C7D4090B1928597960B4E53", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the statement of\n\t\t\t\tquantity or volume, as appropriate;"}, "enum": {"#tail": "\n                      ", "#text": "(IV)"}, "@id": "id35006F734B9A4EFE993F5315480589B6", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to ensure that no residues from the\n\t\t\t\tcompounded drug can be detected in edible tissues of the treated animal;", "@entity-type": "act", "#text": "subsection (e)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:5", "@proposed": "true"}, "#text": "in the case of a\n\t\t\t\tdrug intended for use in a food-producing animal, the withdrawal period\n\t\t\t\testablished pursuant to "}, "enum": {"#tail": "\n                      ", "#text": "(V)"}, "#text": "\n                      ", "@id": "idF155FE2DFFC943C8A890E6AECF0A334C", "@commented": "no"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the date that\n\t\t\t\tthe drug was compounded;"}, "enum": {"#tail": "\n                      ", "#text": "(VI)"}, "@id": "id9A4E22B47FF24DA58509C5A3AC0C3043", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the expiration\n\t\t\t\tdate;"}, "enum": {"#tail": "\n                      ", "#text": "(VII)"}, "@id": "idBA6A6BA1F5224E48BA527F9C9FA10EB3", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "storage and\n\t\t\t\thandling instructions;"}, "enum": {"#tail": "\n                      ", "#text": "(VIII)"}, "@id": "id00ED99928063475198FD493712A63AD0", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the National\n\t\t\t\tDrug Code number, if available;"}, "enum": {"#tail": "\n                      ", "#text": "(IX)"}, "@id": "id89912486FA3E4795AC229EC8799C8346", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "quote": {"#tail": " statement required as required by ", "#text": "not\n\t\t\t\tfor resale"}, "#text": "the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";\n\t\t\t\tand", "@entity-type": "act", "#text": "subsection (f)(1)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:f/p:1/sp:C", "@proposed": "true"}}, "enum": {"#tail": "\n                      ", "#text": "(X)"}, "@id": "id16D3AEFC29F849E9910F7BFC4F8F6706", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a list of active and inactive ingredients, identified by\n\t\t\t\testablished name and the quantity or proportion of each ingredient.", "@entity-type": "act", "#text": "subparagraph (B)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:4/sp:B/cl:i", "@proposed": "true"}, "#text": "subject to\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(XI)"}, "@id": "id4A5481B063E242438C52367809D2F800", "#text": "\n                      "}], "#text": "\n                    ", "@id": "idDA79C079705C49D680CB5D5A73939C49"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Label"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tlabel of a drug compounded by a compounding manufacturer shall include\u2014"}, "#text": "\n                  ", "@id": "id4160257BA70E4DB09C183EB7536E8BD5"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", if there is not space on the label\n\t\t\t\tfor such information;", "@entity-type": "act", "#text": "subparagraph (A)(iii)(XI)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:4/sp:A/cl:iii/scl:XI", "@proposed": "true"}, "#text": "the information\n\t\t\t\tdescribed under "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id1D3436D0D1964BAEBD418037FA980897", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the following\n\t\t\t\tinformation to facilitate adverse event reporting: www.fda.gov/medwatch and\n\t\t\t\t1\u2013800\u2013FDA\u20131088; and"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idF2AD1B75764C47BA8843EF9FF7C35F09", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the directions\n\t\t\t\tfor use, including dosage and administration, as appropriate."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id402E5EEB89C74CD9BE1FD41ACA0510BD", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Container"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tcontainer from which the individual units of a drug compounded by a compounding\n\t\t\t\tmanufacturer are removed for dispensing or for administration (such as a\n\t\t\t\tplastic bag containing individual product syringes) shall include\u2014"}, "#text": "\n                  ", "@id": "idBF9D24476221410DB739170EA4A20223"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The label and labeling of a drug compounded by a\n\t\t\t\tcompounding manufacturer shall include any other information as determined\n\t\t\t\tnecessary and specified in regulations promulgated by the "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Additional\n\t\t\t\tinformation"}, "#text": "\n                  ", "@id": "id2E2F356AB737472DADCF85AC0772A43B"}], "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Labeling of\n\t\t\t\tdrugs"}, "#text": "\n                ", "@id": "id0AA77FC0E39444BAB5F72E640E31C6A5"}], "#text": "\n              ", "@id": "idA1CF6C69CC38432C8CE3FB744EF3A80B"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(h)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Compounding\n\t\t\t\tmanufacturer establishment and reinspection fees"}, "paragraph": [{"#tail": "\n              ", "@id": "idFBE027F0B55B435B8358609AD0D8B6F1", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Definitions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis subsection\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section\n\t\t\t\t735(11)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:11"}, "term": {"#tail": " has the meaning given such term in ", "#text": "affiliate"}, "#text": "the term\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id0E812543AC0C4B628D41944F106355F2", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means the total worldwide gross annual sales,\n\t\t\t\tin United States dollars, for a compounding manufacturer, including the sales\n\t\t\t\tof all the affiliates of the compounding manufacturer; and", "#text": "gross annual sales"}, "#text": "the term\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id05593E120B514D3EAB554172E2A92A80", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " subsequent to an inspection\n\t\t\t\tconducted under such provision which identified noncompliance materially\n\t\t\t\trelated to an applicable requirement of this Act, specifically to determine\n\t\t\t\twhether compliance has been achieved to the ", "@entity-type": "act", "#text": "section 704", "@value": "Federal Food, Drug, and Cosmetic Act/s:704"}, {"#tail": "'s satisfaction.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "term": {"#tail": " means, with respect to a compounding manufacturer,\n\t\t\t\tone or more inspections conducted under ", "#text": "reinspection"}, "#text": "the term\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id1BBD8AD567AE484A8660B9D434340031", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "id0AC78BF864B945B4B9A7296026CE7BF1", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Establishment\n\t\t\t\tand reinspection fees"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall, in accordance with this subsection, assess\n\t\t\t\tand collect\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "For fiscal year 2015 and each subsequent\n\t\t\t\tfiscal year, the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "an annual\n\t\t\t\testablishment fee from each compounding manufacturer to cover\n\t\t\t\tinspection-related costs relating to inspections of drug compounders for such\n\t\t\t\tyear; and"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idD0B43E623D4F4E5DA9978793DFCB5966", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "a reinspection\n\t\t\t\tfee from each compounding manufacturer subject to a reinspection in such fiscal\n\t\t\t\tyear."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id9EDA004698854CF885E6476F8590800E", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish the\n\t\t\t\testablishment and reinspection fee to be collected under this subsection for\n\t\t\t\teach fiscal year, based on the methodology described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and shall\n\t\t\t\tpublish such fee in a Federal Register notice not later than 60 days before the\n\t\t\t\tstart of each such year.", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Establishment\n\t\t\t\tand reinspection fee setting"}, "#text": "\n                ", "@id": "id6719D59CBC3643459A8CDBCA43374558"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "$15,000 per compounding\n\t\t\t\tmanufacturer, multiplied by"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                      ", "@id": "id1C21232DACE6477BBC689ECFEB746A81", "@commented": "no"}, {"@indent": "up1", "#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; plus", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:B", "@proposed": "true"}, "#text": "the inflation adjustment factor\n\t\t\t\tdescribed in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "#text": "\n                      ", "@id": "id5DABEF08D4EF48C0A72803614A4D5FF3"}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idD20AB76C5BC04657BE997C28041CF09F", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:C", "@proposed": "true"}, "#text": "the small\n\t\t\t\tbusiness adjustment factor described in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id188D198538E946DFA112125CA3D09F50", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the amount of the\n\t\t\t\tannual establishment fee and the reinspection fee (if applicable) under\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:D", "@proposed": "true"}, {"#tail": " for each compounding manufacturer in a fiscal year shall be equal\n\t\t\t\tto the sum of\u2014", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:2", "@proposed": "true"}], "#text": "Except as provided in "}, "#text": "\n                  ", "@id": "idC23EA184F02D4C9EA1EE4FCBAF700759"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "one;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "ID86599264058A44F785C46FEAB22F3EFA", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", of all personnel compensation and benefits paid\n\t\t\t\twith respect to such positions for the first 3 years of the preceding 4 fiscal\n\t\t\t\tyears, multiplied by the proportion of personnel compensation and benefits\n\t\t\t\tcosts to total costs of an average full-time equivalent position of the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " for the first 3 years of the preceding 4 fiscal years,\n\t\t\t\tand", "@entity-type": "federal-body", "#text": "Food\n\t\t\t\tand Drug Administration", "@entity-id": "7524"}], "#text": "the average\n\t\t\t\tannual percent change in the cost, per full-time equivalent position of the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "ID71524C26EF4E4DAFB92C29E93D94BDC6", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for the first 3 years of the preceding 4 fiscal\n\t\t\t\tyears.", "@entity-type": "federal-body", "#text": "Food\n\t\t\t\tand Drug Administration", "@entity-id": "7524"}, "#text": "the average\n\t\t\t\tannual percent change that occurred in the Consumer Price Index for urban\n\t\t\t\tconsumers (U.S. City Average; Not Seasonally Adjusted; All items; Annual Index)\n\t\t\t\tfor the first 3 years of the preceding 4 years of available data multiplied by\n\t\t\t\tthe proportion of all costs other than personnel compensation and benefits\n\t\t\t\tcosts to total costs of an average full-time equivalent position of the "}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "IDA60B05E9F00446FCA95561C70192E769", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be adjusted by the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:A", "@proposed": "true"}, {"#tail": " by\n\t\t\t\tnotice, published in the Federal Register, for a fiscal year by the amount\n\t\t\t\tequal to the sum of\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For fiscal year 2015 and subsequent fiscal years, the\n\t\t\t\trevenues established in "}, "#text": "\n                    ", "@id": "ID6E333A3737EA4C18B5D81B506A2CD4E5"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t\tbe added on a compounded basis to the sum of all adjustments made each fiscal\n\t\t\t\tyear after fiscal year 2014 under ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:B/cl:i", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:B/cl:i", "@proposed": "true"}], "#text": "The adjustment made each fiscal year under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Compounded\n\t\t\t\tbasis"}, "#text": "\n                    ", "@id": "ID8C4991E0CD3042B693EB4CACB0D9E9B6"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Inflation\n\t\t\t\tadjustment factor"}, "#text": "\n                  ", "@id": "idDE58CF307A464477992F58B17836C296"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the number of\n\t\t\t\tsmall businesses that will pay a reduced establishment fee for such fiscal\n\t\t\t\tyear; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idf96d564b5bc14f51b89b2c6a6b5be5af", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " would have collected if no entity qualified for the\n\t\t\t\tsmall business exception in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:D", "@proposed": "true"}], "#text": "the adjustment\n\t\t\t\tto the establishment fee necessary to achieve total fees equaling the total\n\t\t\t\tfees that the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id32d67b5fe01f44bc8b28926f847eead9", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Small business\n\t\t\t\tadjustment factor"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be an amount established by the ", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:A/cl:ii", "@proposed": "true"}, {"#tail": " for\n\t\t\t\teach fiscal year based on the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\u2019s estimate of\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The small business adjustment factor described\n\t\t\t\tin "}, "#text": "\n                  ", "@id": "id8D2CB783774947D7A168BAB953D107C0"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal year shall be equal to\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:2", "@proposed": "true"}, {"#tail": " in\n\t\t\t\tsuch fiscal year.", "@entity-type": "act", "#text": "subparagraph (A)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:A/cl:i", "@proposed": "true"}], "#text": "In the case of a compounding manufacturer with gross\n\t\t\t\tannual sales of $1,000,000 or less in the 12 months ending June 1 of the fiscal\n\t\t\t\tyear immediately preceding the fiscal year in which the fees under this\n\t\t\t\tsubsection are assessed, the amount of the establishment fee and reinspection\n\t\t\t\tfee under ", "fraction": {"#tail": " of the amount calculated under ", "#text": "1/3"}}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "id5BF05A8C2F5B43A4A7F08623C2952E5D"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may require a small business to apply for the exception under this\n\t\t\t\tsubparagraph by certifying its gross annual sales for the 12 months ending June\n\t\t\t\t1 of the fiscal year immediately preceding the fiscal year in which fees under\n\t\t\t\tthis subsection are assessed. Any such application must be submitted to the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " prior to August 1 for the following fiscal year. Any statement or\n\t\t\t\trepresentation made to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall be subject to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "uscode", "#text": "section 1001 of title\n\t\t\t\t18, United States Code", "@value": "usc/18/1001"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Application"}, "#text": "\n                    ", "@id": "idABD9ACED9D2E443C9D9082AFCD35903D"}], "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Exception for\n\t\t\t\tsmall businesses"}, "#text": "\n                  ", "@id": "id29BAF1FF035D4E6688AEF1AEE562F685"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal year, the ", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:C", "@proposed": "true"}, {"#tail": " shall provide for the\n\t\t\t\tcrediting of fees from the previous year to the next year if the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\toverestimated the amount of the small business adjustment factor for such\n\t\t\t\tprevious fiscal year, and consider the need to account for any adjustment of\n\t\t\t\tfees and such other factors as the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " determines appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In establishing the small business adjustment factor under\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Crediting of\n\t\t\t\tfees"}, "#text": "\n                  ", "@id": "id802D70D4249C48E6BA41B241D9774888"}], "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Amount of\n\t\t\t\testablishment and reinspection fee"}, "#text": "\n                ", "@id": "id1054C35293E94A20A55797AD35A5B63E"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make all of the fees collected pursuant\n\t\t\t\tto ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:2/sp:A", "@proposed": "true"}, {"#tail": " available solely to pay for the\n\t\t\t\tinspection-related costs (including re-inspection) for the oversight of drug\n\t\t\t\tcompounding.", "@entity-type": "act", "#text": "(B) of paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:2/sp:B", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Use of\n\t\t\t\tfees"}, "#text": "\n                ", "@id": "id00B30E856F5F4EDCA8C17944D67BB9A5"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " pursuant to this\n\t\t\t\tsubsection shall be used to supplement and not supplant any other Federal funds\n\t\t\t\tavailable to carry out the activities described in this subsection.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Funds received by the "}, "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n                ", "#text": "Supplement not\n\t\t\t\tsupplant"}, "#text": "\n                ", "@id": "ide5364325e8034b1a86c67e90f8af77e6"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " salaries and expenses appropriation account\n\t\t\t\twithout fiscal year limitation to such appropriation account for salaries and\n\t\t\t\texpenses with such fiscal year limitation. The sums transferred shall be\n\t\t\t\tavailable solely for the purpose of paying the inspection-related costs\n\t\t\t\t(including reinspection) for the oversight of drug compounding.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "Fees authorized under this subsection shall\n\t\t\t\tbe collected and available for obligation only to the extent and in the amount\n\t\t\t\tprovided in advance in appropriations Acts. Such fees are authorized to remain\n\t\t\t\tavailable until expended. Such sums as may be necessary may be transferred from\n\t\t\t\tthe "}, "enum": {"#tail": "\n                ", "#text": "(7)"}, "header": {"#tail": "\n                ", "#text": "Crediting and\n\t\t\t\tavailability of fees"}, "#text": "\n                ", "@id": "ID7A6A9D0587AC4CBE986A2BE6AC3FFE74"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for such fiscal year.", "@entity-type": "act", "#text": "subsection (g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g", "@proposed": "true"}, "#text": "A compounding manufacturer shall remit the establishment fee\n\t\t\t\tdue under this subsection in a fiscal year when submitting a registration\n\t\t\t\tpursuant to "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Establishment\n\t\t\t\tfee"}, "#text": "\n                  ", "@id": "idE1E8407602FD43A3BDB112066558EF95"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall specify in the Federal Register notice\n\t\t\t\tdescribed in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " the manner in which reinspection fees assessed under\n\t\t\t\tthis subsection shall be collected and the timeline for payment of such fees.\n\t\t\t\tSuch a fee shall be collected after the ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:3", "@proposed": "true"}, {"#tail": " has conducted a reinspection\n\t\t\t\tof the compounding manufacturer involved.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Reinspection\n\t\t\t\tfee"}, "#text": "\n                  ", "@id": "ID5C0310B27F7E4602A1DD22A717221E39"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in a fiscal year until the date that the compounding manufacturer remits\n\t\t\t\tthe establishment fee under this subsection for such fiscal year.", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g", "@proposed": "true"}, "#text": "A\n\t\t\t\tcompounding manufacturer shall not be considered registered under "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Registration"}, "#text": "\n                    ", "@id": "id4721DF18986A44648676921A6864255A"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " until the fees owed for such\n\t\t\t\tcompounding manufacturer under this subsection have been paid.", "@entity-type": "act", "#text": "section 502(cc)", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:cc"}, "#text": "All\n\t\t\t\tdrugs compounded by a compounding manufacturer for which any establishment fee\n\t\t\t\tor reinspection fee has not been paid as required by this subsection shall be\n\t\t\t\tdeemed misbranded under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Misbranding"}, "#text": "\n                    ", "@id": "id0EAB03EFFE334F0FB4CEAA0DAA05F667"}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Effect of\n\t\t\t\tfailure to pay fees"}, "#text": "\n                  ", "@id": "idCA36C67CD9A94D7593B21209A1F1199B"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not receive\n\t\t\t\tpayment of a fee assessed under this subsection within 30 days after it is due,\n\t\t\t\tsuch fee shall be treated as a claim of the United States Government subject to\n\t\t\t\tprovisions of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "uscode", "#text": "subchapter II of ", "external-xref": {"#tail": " of title 31, United States\n\t\t\t\tCode", "@parsable-cite": "usc-chapter/31/37", "#text": "chapter 37", "@legal-doc": "usc-chapter"}, "@value": "usc-chapter/31/37/II"}], "#text": "In any case where the "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Collection of\n\t\t\t\tunpaid fees"}, "#text": "\n                  ", "@id": "IDD835A99A591A4272B9C3554ED59B5A64"}], "enum": {"#tail": "\n                ", "#text": "(8)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Collection of\n\t\t\t\tfees"}, "#text": "\n                ", "@id": "ID84BCEC0EE2534EC0AAFFF080FC3C8F77"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tshall submit a report to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Health, Education, Labor, and\n\t\t\t\tPensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": ", to include a description of fees assessed and collected for\n\t\t\t\teach year, a summary description of entities paying the fees, and the number of\n\t\t\t\tinspections and reinspections of such entities performed each year.", "@entity-type": "committee", "#text": "Committee on Energy and Commerce of the House of\n\t\t\t\tRepresentatives", "@entity-id": "HIF00"}], "#text": "Not later than 120 days after each fiscal year in\n\t\t\t\twhich fees are assessed and collected under this subsection, the "}, "enum": {"#tail": "\n                ", "#text": "(9)"}, "header": {"#tail": "\n                ", "#text": "Annual report\n\t\t\t\tto congress"}, "#text": "\n                ", "@id": "ID0A6668F2D1AC43238BF35D57E3032C90", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "\n                  ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "this subsection", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h", "@proposed": "true"}, "@entity-type": "auth-auth-approp", "#text": "\n                    ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ", there is authorized to be appropriated for fees under this subsection an\n\t\t\t\tamount equivalent to the total amount of fees assessed for such fiscal year\n\t\t\t\tunder ", "#text": "For fiscal year 2015 and each subsequent fiscal\n\t\t\t\tyear", "@amount": "indefinite", "@year": "2015,.."}}}, "enum": {"#tail": "\n                ", "#text": "(10)"}, "header": {"#tail": "\n                ", "#text": "Authorization\n\t\t\t\tof appropriations"}, "#text": "\n                ", "@id": "ID00940E566BAF4BCAA03683F6C010BBF9"}], "#text": "\n              ", "@id": "idD8FB9353725F4B0CAF2CD7C4B706210C"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Action by\n\t\t\t\tSecretary regarding complaints from State boards of pharmacy"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall designate a point of contact and establish a format and\n\t\t\t\tprocedure for a State Board of Pharmacy to notify the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " if it appears\n\t\t\t\tto a State Board of Pharmacy that an entity licensed by a State as a pharmacy\n\t\t\t\tis required to be registered with the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " as a compounding\n\t\t\t\tmanufacturer.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Designation"}, "#text": "\n                ", "@id": "id8d3d69653815448f9c07e50fe468179f"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " determines that such an entity described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " is\n\t\t\t\trequired to be registered with the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:i/p:1", "@proposed": "true"}, {"#tail": " as a compounding manufacturer, the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall transmit such determination to the State Board of Pharmacy in\n\t\t\t\tthe State in which the entity is located, and to the State Board of Pharmacy in\n\t\t\t\tthe notifying State, if different, within 15 days of such determination.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If\n\t\t\t\tthe "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Determination"}, "#text": "\n                ", "@id": "ide7fc305dcedd4b96ab0f8908ab885d23"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall encourage direct communications between States regarding\n\t\t\t\ttraditional compounders. Nothing in this subsection shall expand the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " authority over or responsibility for traditional\n\t\t\t\tcompounding.", "@entity-type": "federal-body", "#text": "Secretary\u2019s", "@entity-id": "7500"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Effect"}, "#text": "\n                ", "@id": "idd1e3de8f0c724857988f1c04046e2b6d"}], "#text": "\n              ", "@id": "id0fd8d114d3264442917d796b95fe9936", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "For purposes of this section, reference to a\n\t\t\t\tprescription order for an identified individual patient includes, in the case\n\t\t\t\tof animal drugs, a prescription order for a specific herd or flock (or other\n\t\t\t\tidentified group) of\n\t\t\t\tanimals."}, "enum": {"#tail": "\n              ", "#text": "(j)"}, "header": {"#tail": "\n              ", "#text": "Prescription\n\t\t\t\torder reference"}, "#text": "\n              ", "@id": "idBC94F52C9BC041CD9D70142EA0CBB338"}], "#text": "\n            ", "@id": "idE07EB9835DF84C7DAFCF5DC95A117686"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "idB47FC16A0245444EA736D7F23B24F1D1"}, "#text": "\n        ", "@id": "idA9E0FBDB0FBB4DF4A49C2AF54628A533"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 301", "@value": "Federal Food, Drug, and Cosmetic Act/s:301"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 331", "@value": "usc/21/331"}, "@parsable-cite": "usc/21/331", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Prohibited\n\t\t\t act"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "subsection\n\t\t\t (e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:e"}, "#text": "in ", "quote": [{"#tail": " and inserting ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "417", "@value": "Federal Food, Drug, and Cosmetic Act/s:417"}, {"#tail": ", ", "@entity-type": "act", "#text": "416", "@value": "Federal Food, Drug, and Cosmetic Act/s:416"}, {"#tail": "\n            ", "@entity-type": "act", "#text": "504", "@value": "Federal Food, Drug, and Cosmetic Act/s:504"}], "#text": "\n              "}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "417", "@value": "Federal Food, Drug, and Cosmetic Act/s:417"}, {"#tail": ",\n\t\t\t ", "@entity-type": "act", "#text": "416", "@value": "Federal Food, Drug, and Cosmetic Act/s:416"}, {"#tail": ", ", "@entity-type": "act", "#text": "503A(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g", "@proposed": "true"}, {"#tail": "\n            ", "@entity-type": "act", "#text": "504", "@value": "Federal Food, Drug, and Cosmetic Act/s:504"}], "#text": "\n              "}]}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "id7A14832EB8C1435489E8DD9F70C2E396", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "by adding at the\n\t\t\t end the following:"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "subsection": {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "quote": {"#tail": " as required by\n\t\t\t\t", "#text": "not for resale"}, "#text": "The resale of a\n\t\t\t\tcompounded drug that is labeled ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A", "@proposed": "true"}}, "enum": {"#tail": "\n              ", "#text": "(ccc)"}, "@id": "id05F3DE114692403E955BC88352C2CA87", "#text": "\n              "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "idBAF5A9A10D1742DB9F1C8AFCBB8A1D23"}, "#text": "\n          ", "@id": "id4F611AF35DB04390893F9E21D418EF10"}], "#text": "\n        ", "@id": "idB3D5A38BF4604BD2910BDDC6E0ADEA18"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall conduct study and submit to ", "@entity-type": "federal-body", "#text": "Comptroller General of\n\t\t\t the United States", "@entity-id": "0500"}, {"#tail": " a report regarding\n\t\t\t the impact of this Act (and the amendments made by this Act) on the safety of\n\t\t\t animal drug compounding and the availability of safe and effective drugs for\n\t\t\t animals.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#text": "Not later than November 1, 2016, the "}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Report by\n\t\t\t GAO"}, "#text": "\n        ", "@id": "idF2B2954B49D24184A34078B8D8D700C7"}], "#text": "\n      ", "@id": "id7E19EFA14F4B4868A468C60F026D1740"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Other\n\t\t\t requirements relating to compounding manufacturers"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by\n\t\t\t adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 502", "@value": "Federal Food, Drug, and Cosmetic Act/s:502"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 352", "@value": "usc/21/352"}, "@parsable-cite": "usc/21/352", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Labeling"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subsections (f)(1)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:f/p:1/sp:C", "@proposed": "true"}, {"#tail": ", as applicable.", "@entity-type": "act", "#text": "(g)(4) of section 503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:4", "@proposed": "true"}], "#text": "If it is a\n\t\t\t\tcompounded drug and the labeling does not include the information as required\n\t\t\t\tby "}, "enum": {"#tail": "\n            ", "#text": "(bb)"}, "@id": "idF96D8B759C15433EB5C85A511CC5F631", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t503A(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g", "@proposed": "true"}, "#text": "If it is a drug,\n\t\t\t\tand it was compounded by a compounding manufacturer for which fees have not\n\t\t\t\tbeen paid as required by "}, "enum": {"#tail": "\n            ", "#text": "(cc)"}, "@id": "id15EF37DE857C4A019473B0B540DF25A6", "#text": "\n            "}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id763EF671E5794D229D0C570CB18BF934"}, "#text": "\n        ", "@id": "id66EB604B5AD848C0B9CF6B6B22E2CE9E"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following\n\t\t\t flush text:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 704(a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:704/ss:a/p:2"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 374(a)(2)", "@value": "usc/21/374/a/2"}, "@parsable-cite": "usc/21/374", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Application of\n\t\t\t inspection requirements to compounding manufacturers"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "quoted-block-continuation-text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not apply with respect to compounding\n\t\t\t\tmanufacturers (as such term is defined in ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:704/ss:a/p:2/sp:A"}, {"#tail": ").", "@entity-type": "act", "#text": "section\n\t\t\t\t503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A", "@proposed": "true"}], "#text": "The\n\t\t\t\texemption in ", "@quoted-block-continuation-text-level": "subsection"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "idD905BE9E04294D2FAF4510F9751D906A"}, "#text": "\n        ", "@id": "id8A1FF9E1E4354A3196B3516BC7A5431A"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is amended by striking ", "@entity-type": "act", "#text": "Section\n\t\t\t 402(a)(2)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:402/ss:a/p:2/sp:C"}, "#text": "\n          ", "quote": [{"#tail": " and inserting\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, "#text": "\n            "}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or (iii) any residue from a compounded animal drug;", "@entity-type": "act", "#text": "512", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, "#text": "\n            "}]}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Adulteration of\n\t\t\t compounded animal drugs containing drug residues"}, "#text": "\n        ", "@id": "id6C4CD85E10E040ACB3F6EADBDEC5670B"}], "#text": "\n      ", "@id": "id7198612A26904983A02CEDBD7F6F812C"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary of Health and\n\t\t\t Human Services", "@entity-id": "7500"}, "#text": "In promulgating any regulations to implement\n\t\t\t this Act (and the amendments made by this Act), the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Implementation"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "issue a notice of\n\t\t\t proposed rulemaking that includes the proposed regulation;"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "idfaa21d2a856d46b7b3b3c81f9530e1cd", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "provide a period\n\t\t\t of not less than 60 days for comments on the proposed regulation; and"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "idb08c95274883468194c989ad5d9cbe72", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "publish the final\n\t\t\t regulation not more than 18 months following publication of the proposed rule\n\t\t\t and not less than 30 days before the effective date of such final\n\t\t\t regulation."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "idaecff12bfa6548d79f9f852978b98d21", "@commented": "no"}], "#text": "\n      ", "@id": "id310111ED2A9245A3BED7174E7D1C2811"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t", "#text": "This Act (and the\n\t\t\t amendments made by this Act) shall take effect on the date that is 1 year after\n\t\t\t the date of enactment of this Act.", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n      ", "#text": "Effective\n\t\t\t date"}, "@display-inline": "no-display-inline", "#text": "\n      ", "@id": "idA41E64A175CA4A088F1F8B1EFFE7F414", "@commented": "no"}], "#text": "\n\t\t"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-05-15"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S959 IS: Pharmaceutical Compounding Quality and Accountability Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}